Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466017) titled 'A Study of CS060380 Tablets in Patients With MASH and Obesity' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Cascade Pharmaceuticals, Inc
Condition:
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Obesity
Intervention:
Drug: semaglutide
Drug: CS060380
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 14, 2026
Target Sample Size: 120
Countries of Recruitment:
China
T...